Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which block works best for hemorrhoid pain?

NCT ID NCT07350460

Symptom relief Sponsor: Andrea Saporito Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two types of nerve blocks to control pain after hemorrhoid surgery. One group gets a pudendal block, the other a sacral ESP block, both using the same numbing medicine. Researchers will measure pain levels and how quickly patients recover. The goal is to find which block provides better pain relief and faster recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ropivacaine
What this could lead to
If successful, this could show that the sacral ESP block provides equal or better pain control than the pudendal block, improving recovery after hemorrhoid surgery.
What could go wrong
This is a small, early-phase trial with only 64 participants, so results may not apply to everyone. Pain relief varies by individual, and the sham injections may cause some discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 64 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jan 2026

Expected to finish

Sep 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults (≥18 years old) scheduled for elective excisional hemorrhoidectomy; * Ability to understand the nature of the study and provide written informed consent; * American Society of Anesthesiologists (ASA) physical status I-III; * Ability to comply with study procedures and postoperative evaluations. Exclusion Criteria: * Pregnancy; * Body weight under 50 kg due to the potential risk of local anaesthetic systemic toxicity (LAST); * BMI \> 40; Known allergy or contraindication to local anaesthetics (e.g., ropivacaine, prilocaine); * Severe coagulation disorders or current anticoagulant therapy contraindicating spinal or peripheral deep nerve blocks (like pudendal block, because Sacral ESP is considered a superficial block); * Infection at the puncture site; * Neurological disorders affecting the sacral or pudendal nerve pathways; * Severe psychiatric conditions impairing study participation; * Language barriers

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hemorrhoids are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

hemorrhoid Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Hemorrhoids Hemorrhoids third degree

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ospedale Regionale Bellinzona e Valli (ORBV) CH-6500 Bellinzona Switzerland

    RECRUITING

    Bellinzona, 6500, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.